Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1
Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1

Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1

  • Faculty: Program director Joseph Basha, CCP
  • Date: December 10th, 2019 7:45 pm
  • CEU’s: 3 CEUs
  • Price: $45
  • Category 3 CEU
Buy Course
Course Rating:
(3 Reviews)

Latest Reviews

View All

Course description

Perfweb #31 - Day 1

Topics for this program: Unwanted intravascular material and its consequences w/Case studies 
Introducing the AngioVac Gen 3 
Incorporating AngioVac Gen 3 into a comprehensive Pulmonary Embolism (PE) Response program 
Use of AngioVac with Oxygenation and MCS (Demonstration) __________________________________________________________________ 
Follow Us on Twitter: https://twitter.com/nola_conference __________________________________________________________________  
#perfusion #angiovac #pulmonaryembolism 
 _________________________________________________________________ 
 Please visit our sponsor links below: 

Meet Your Instructor

Program director Joseph Basha, CCP

Program director Joseph Basha, CCP

Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference

Read Full Bio